|Articles|November 1, 2002
Study results promising: Antibiotic product treats conjunctivitis effectively
Alameda, CA-InSite Vision Inc.'s antibiotic product ISV-401 has proved safe and effective for treating acute bacterial conjunctivitis in a phase II clinical study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Achieving a new level of refractive precision: Surgical strategies
4
The year in optometry: 10 stories that defined eye care in 2025
5